Comments
Loading...
Tharimmune (THAR) Forecast
NewsEarningsTharimmune (THAR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTharimmune (NASDAQ:THAR) Stock Quotes, Forecast and News Summary
Tharimmune Stock (NASDAQ: THAR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Tharimmune (THAR) stock?
You can purchase shares of Tharimmune (NASDAQ:THAR) through any online brokerage.
Who are Tharimmune (THAR) competitors?
Other companies in Tharimmune’s space includes: Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX), Palisade Bio (NASDAQ:PALI), Portage Biotech (NASDAQ:PRTG) and AquaBounty Techs (NASDAQ:AQB).
What is the forecast, or price target, for Tharimmune (THAR) stock?
There is no analysis for Tharimmune to provide a consensus price target.
What is the current price for Tharimmune (THAR)?
The stock price for Tharimmune (NASDAQ: THAR) is $2.53 last updated November 21, 2024 at 10:57 AM EST.
Does Tharimmune (THAR) pay a dividend?
There are no upcoming dividends for Tharimmune.
When is Tharimmune (NASDAQ:THAR) reporting earnings?
Tharimmune’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Tharimmune (THAR) going to split?
There is no upcoming split for Tharimmune.
What sector and industry does Tharimmune (THAR) operate in?
Tharimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.